Annals of Medicine

The *Annals of Medicine* (ANN MED, ISSN 0785-3890) is a premier, peer-reviewed international journal dedicated to advancing knowledge across the breadth of clinical and translational medicine. With a distinguished Impact Factor of 4.9000 for 2026 and a consistent presence in the JCR Q1 quartile, the journal serves as a high-impact platform for innovative research that bridges the gap between laboratory discoveries and patient care. Its scope encompasses a wide array of medical specialties, including but not limited to internal medicine, cardiology, oncology, neurology, endocrinology, and epidemiology, with a particular emphasis on studies that inform clinical practice, disease mechanisms, and therapeutic strategies. The journal publishes a diverse range of article types to cater to the dynamic needs of the medical research community. These include original research articles, comprehensive review articles, systematic reviews and meta-analyses, case series, study protocols, and insightful editorials. This variety ensures that the *Annals of Medicine* remains a vital resource for both cutting-edge findings and synthesized clinical knowledge. The primary target audience comprises clinicians, academic researchers, medical educators, and healthcare policymakers who require rigorous, evidence-based information to guide decision-making and further investigation. Published as a fully open access journal by Taylor & Francis, the *Annals of Medicine* ensures that all its content is freely and permanently available online, maximizing global dissemination and impact. Its standing as a Q1 journal reflects its significant influence and high citation rates within the medical sciences, solidifying its reputation as a leading forum for impactful research that shapes contemporary medical understanding and practice.